AU2019394875A1 - Artificial antigen presenting cells including HLA-E and HLA-G molecules and methods of use - Google Patents

Info

Publication number

AU2019394875A1

AU2019394875A1 AU2019394875A AU2019394875A AU2019394875A1 AU 2019394875 A1 AU2019394875 A1 AU 2019394875A1 AU 2019394875 A AU2019394875 A AU 2019394875A AU 2019394875 A AU2019394875 A AU 2019394875A AU 2019394875 A1 AU2019394875 A1 AU 2019394875A1

Authority

AU

Australia

Prior art keywords

cell

polypeptide

exogenous

aapc

cells

Prior art date

2018-12-03

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Links

• Espacenet
• Global Dossier
• Discuss

• 210000000612 antigen-presenting cell Anatomy 0.000 title claims abstract description 47
• 238000000034 method Methods 0.000 title claims description 128
• 108010024164 HLA-G Antigens Proteins 0.000 title claims description 125
• 102100028967 HLA class I histocompatibility antigen, alpha chain G Human genes 0.000 title description 3
• 102100028970 HLA class I histocompatibility antigen, alpha chain E Human genes 0.000 title description 2
• 101000986085 Homo sapiens HLA class I histocompatibility antigen, alpha chain E Proteins 0.000 title 1
• 210000004027 cell Anatomy 0.000 claims abstract description 459
• 210000000267 erythroid cell Anatomy 0.000 claims abstract description 250
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 1046
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 1020
• 229920001184 polypeptide Polymers 0.000 claims description 1011
• 230000000890 antigenic effect Effects 0.000 claims description 204
• 210000001744 T-lymphocyte Anatomy 0.000 claims description 139
• 210000002865 immune cell Anatomy 0.000 claims description 125
• 230000000139 costimulatory effect Effects 0.000 claims description 99
• 239000012528 membrane Substances 0.000 claims description 98
• 150000007523 nucleic acids Chemical class 0.000 claims description 90
• 108091005250 Glycophorins Proteins 0.000 claims description 84
• 102000039446 nucleic acids Human genes 0.000 claims description 84
• 108020004707 nucleic acids Proteins 0.000 claims description 84
• 102100035716 Glycophorin-A Human genes 0.000 claims description 83
• 108090000623 proteins and genes Proteins 0.000 claims description 77
• 239000000427 antigen Substances 0.000 claims description 72
• 108091007433 antigens Proteins 0.000 claims description 71
• 102000036639 antigens Human genes 0.000 claims description 71
• 210000003289 regulatory T cell Anatomy 0.000 claims description 64
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 54
• 210000003719 b-lymphocyte Anatomy 0.000 claims description 51
• 102000004169 proteins and genes Human genes 0.000 claims description 40
• 210000003013 erythroid precursor cell Anatomy 0.000 claims description 38
• 238000004519 manufacturing process Methods 0.000 claims description 36
• 208000027866 inflammatory disease Diseases 0.000 claims description 33
• 208000023275 Autoimmune disease Diseases 0.000 claims description 32
• 210000000822 natural killer cell Anatomy 0.000 claims description 28
• 230000000694 effects Effects 0.000 claims description 27
• 210000004443 dendritic cell Anatomy 0.000 claims description 26
• 239000012634 fragment Substances 0.000 claims description 26
• 210000002540 macrophage Anatomy 0.000 claims description 26
• 150000001413 amino acids Chemical class 0.000 claims description 25
• 208000035475 disorder Diseases 0.000 claims description 24
• 230000003213 activating effect Effects 0.000 claims description 22
• 230000001472 cytotoxic effect Effects 0.000 claims description 22
• 108700028369 Alleles Proteins 0.000 claims description 21
• 102100030584 Small integral membrane protein 1 Human genes 0.000 claims description 17
• 101710200166 Small integral membrane protein 1 Proteins 0.000 claims description 17
• 210000003743 erythrocyte Anatomy 0.000 claims description 17
• -1 CD86 Proteins 0.000 claims description 16
• 108010002350 Interleukin-2 Proteins 0.000 claims description 16
• 231100000433 cytotoxic Toxicity 0.000 claims description 16
• 230000028993 immune response Effects 0.000 claims description 16
• 230000002401 inhibitory effect Effects 0.000 claims description 16
• 210000001995 reticulocyte Anatomy 0.000 claims description 16
• 108010058432 Chaperonin 60 Proteins 0.000 claims description 14
• 230000007159 enucleation Effects 0.000 claims description 14
• 108020001507 fusion proteins Proteins 0.000 claims description 14
• 102000037865 fusion proteins Human genes 0.000 claims description 14
• 230000035755 proliferation Effects 0.000 claims description 14
• 238000012258 culturing Methods 0.000 claims description 13
• 230000005764 inhibitory process Effects 0.000 claims description 13
• 230000001105 regulatory effect Effects 0.000 claims description 13
• 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 claims description 12
• 108090000172 Interleukin-15 Proteins 0.000 claims description 12
• 102000003812 Interleukin-15 Human genes 0.000 claims description 12
• 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 claims description 12
• 239000013598 vector Substances 0.000 claims description 12
• 230000001404 mediated effect Effects 0.000 claims description 11
• 239000000556 agonist Substances 0.000 claims description 10
• 208000026935 allergic disease Diseases 0.000 claims description 10
• 208000009329 Graft vs Host Disease Diseases 0.000 claims description 8
• 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims description 8
• 208000024908 graft versus host disease Diseases 0.000 claims description 8
• 201000006417 multiple sclerosis Diseases 0.000 claims description 8
• 206010039073 rheumatoid arthritis Diseases 0.000 claims description 8
• 102100030704 Interleukin-21 Human genes 0.000 claims description 7
• 208000006673 asthma Diseases 0.000 claims description 7
• 108010074108 interleukin-21 Proteins 0.000 claims description 7
• 238000012546 transfer Methods 0.000 claims description 7
• 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims description 6
• 206010016654 Fibrosis Diseases 0.000 claims description 6
• 208000000592 Nasal Polyps Diseases 0.000 claims description 6
• 108010042215 OX40 Ligand Proteins 0.000 claims description 6
• 102000004473 OX40 Ligand Human genes 0.000 claims description 6
• 230000002327 eosinophilic effect Effects 0.000 claims description 6
• 229940126546 immune checkpoint molecule Drugs 0.000 claims description 6
• 230000006882 induction of apoptosis Effects 0.000 claims description 6
• 210000000265 leukocyte Anatomy 0.000 claims description 6
• 201000008383 nephritis Diseases 0.000 claims description 6
• 239000002243 precursor Substances 0.000 claims description 6
• 230000003614 tolerogenic effect Effects 0.000 claims description 6
• 238000010361 transduction Methods 0.000 claims description 6
• 230000026683 transduction Effects 0.000 claims description 6
• 210000001035 gastrointestinal tract Anatomy 0.000 claims description 5
• 238000000338 in vitro Methods 0.000 claims description 5
• 230000002829 reductive effect Effects 0.000 claims description 5
• 230000001177 retroviral effect Effects 0.000 claims description 5
• 201000000596 systemic lupus erythematosus Diseases 0.000 claims description 5
• 230000003612 virological effect Effects 0.000 claims description 5
• 241000702421 Dependoparvovirus Species 0.000 claims description 4
• 201000002661 Spondylitis Diseases 0.000 claims description 4
• 230000001363 autoimmune Effects 0.000 claims description 4
• 238000004520 electroporation Methods 0.000 claims description 4
• 230000002757 inflammatory effect Effects 0.000 claims description 4
• 238000001638 lipofection Methods 0.000 claims description 4
• 239000002502 liposome Substances 0.000 claims description 4
• 241000701161 unidentified adenovirus Species 0.000 claims description 4
• 241001529453 unidentified herpesvirus Species 0.000 claims description 4
• 208000032671 Allergic granulomatous angiitis Diseases 0.000 claims description 3
• 206010003827 Autoimmune hepatitis Diseases 0.000 claims description 3
• 108010074708 B7-H1 Antigen Proteins 0.000 claims description 3
• 206010006458 Bronchitis chronic Diseases 0.000 claims description 3
• 208000031229 Cardiomyopathies Diseases 0.000 claims description 3
• 206010057645 Chronic Inflammatory Demyelinating Polyradiculoneuropathy Diseases 0.000 claims description 3
• 208000030939 Chronic inflammatory demyelinating polyneuropathy Diseases 0.000 claims description 3
• 208000006344 Churg-Strauss Syndrome Diseases 0.000 claims description 3
• 206010012438 Dermatitis atopic Diseases 0.000 claims description 3
• 206010014561 Emphysema Diseases 0.000 claims description 3
• 208000018428 Eosinophilic granulomatosis with polyangiitis Diseases 0.000 claims description 3
• 206010064212 Eosinophilic oesophagitis Diseases 0.000 claims description 3
• 208000007465 Giant cell arteritis Diseases 0.000 claims description 3
• 206010072579 Granulomatosis with polyangiitis Diseases 0.000 claims description 3
• 208000022559 Inflammatory bowel disease Diseases 0.000 claims description 3
• 206010065390 Inflammatory pain Diseases 0.000 claims description 3
• 208000011200 Kawasaki disease Diseases 0.000 claims description 3
• 208000005777 Lupus Nephritis Diseases 0.000 claims description 3
• 101100407308 Mus musculus Pdcd1lg2 gene Proteins 0.000 claims description 3
• 208000009525 Myocarditis Diseases 0.000 claims description 3
• 206010068786 Overlap syndrome Diseases 0.000 claims description 3
• 206010034277 Pemphigoid Diseases 0.000 claims description 3
• 201000011152 Pemphigus Diseases 0.000 claims description 3
• 108700030875 Programmed Cell Death 1 Ligand 2 Proteins 0.000 claims description 3
• 102100024213 Programmed cell death 1 ligand 2 Human genes 0.000 claims description 3
• 206010039085 Rhinitis allergic Diseases 0.000 claims description 3
• 208000007156 Spondylarthritis Diseases 0.000 claims description 3
• 230000033540 T cell apoptotic process Effects 0.000 claims description 3
• 208000001106 Takayasu Arteritis Diseases 0.000 claims description 3
• 208000024780 Urticaria Diseases 0.000 claims description 3
• 206010047115 Vasculitis Diseases 0.000 claims description 3
• 230000000172 allergic effect Effects 0.000 claims description 3
• 201000010105 allergic rhinitis Diseases 0.000 claims description 3
• 201000008937 atopic dermatitis Diseases 0.000 claims description 3
• 208000010668 atopic eczema Diseases 0.000 claims description 3
• 208000037979 autoimmune inflammatory disease Diseases 0.000 claims description 3
• 206010006451 bronchitis Diseases 0.000 claims description 3
• 208000000594 bullous pemphigoid Diseases 0.000 claims description 3
• 230000000747 cardiac effect Effects 0.000 claims description 3
• 208000007451 chronic bronchitis Diseases 0.000 claims description 3
• 230000001684 chronic effect Effects 0.000 claims description 3
• 208000027157 chronic rhinosinusitis Diseases 0.000 claims description 3
• 230000007882 cirrhosis Effects 0.000 claims description 3
• 208000019425 cirrhosis of liver Diseases 0.000 claims description 3
• 208000018631 connective tissue disease Diseases 0.000 claims description 3
• 201000001981 dermatomyositis Diseases 0.000 claims description 3
• 201000002491 encephalomyelitis Diseases 0.000 claims description 3
• 206010014665 endocarditis Diseases 0.000 claims description 3
• 201000000708 eosinophilic esophagitis Diseases 0.000 claims description 3
• 201000001155 extrinsic allergic alveolitis Diseases 0.000 claims description 3
• 230000004761 fibrosis Effects 0.000 claims description 3
• 230000002440 hepatic effect Effects 0.000 claims description 3
• 208000022098 hypersensitivity pneumonitis Diseases 0.000 claims description 3
• 208000009326 ileitis Diseases 0.000 claims description 3
• 208000028774 intestinal disease Diseases 0.000 claims description 3
• 208000002551 irritable bowel syndrome Diseases 0.000 claims description 3
• 208000001725 mucocutaneous lymph node syndrome Diseases 0.000 claims description 3
• 208000008795 neuromyelitis optica Diseases 0.000 claims description 3
• 201000001976 pemphigus vulgaris Diseases 0.000 claims description 3
• 208000008494 pericarditis Diseases 0.000 claims description 3
• 201000006292 polyarteritis nodosa Diseases 0.000 claims description 3
• 208000009954 pyoderma gangrenosum Diseases 0.000 claims description 3
• 206010043207 temporal arteritis Diseases 0.000 claims description 3
• 238000002054 transplantation Methods 0.000 claims description 3
• 101001094887 Ambrosia artemisiifolia Pectate lyase 1 Proteins 0.000 claims description 2
• 101001123576 Ambrosia artemisiifolia Pectate lyase 2 Proteins 0.000 claims description 2
• 101001123572 Ambrosia artemisiifolia Pectate lyase 3 Proteins 0.000 claims description 2
• 101000573177 Ambrosia artemisiifolia Pectate lyase 5 Proteins 0.000 claims description 2
• 108050003558 Interleukin-17 Proteins 0.000 claims description 2
• 102000013691 Interleukin-17 Human genes 0.000 claims description 2
• 102000003810 Interleukin-18 Human genes 0.000 claims description 2
• 108090000171 Interleukin-18 Proteins 0.000 claims description 2
• 230000000925 erythroid effect Effects 0.000 claims description 2
• 238000001727 in vivo Methods 0.000 claims description 2
• 201000008350 membranous glomerulonephritis Diseases 0.000 claims description 2
• 102000006303 Chaperonin 60 Human genes 0.000 claims 2
• 102000008096 B7-H1 Antigen Human genes 0.000 claims 1
• 108700012920 TNF Proteins 0.000 claims 1
• 102000004127 Cytokines Human genes 0.000 description 59
• 108090000695 Cytokines Proteins 0.000 description 59
• 102000005962 receptors Human genes 0.000 description 43
• 108020003175 receptors Proteins 0.000 description 43
• 235000018102 proteins Nutrition 0.000 description 37
• 230000027455 binding Effects 0.000 description 33
• 230000014509 gene expression Effects 0.000 description 33
• 201000010099 disease Diseases 0.000 description 30
• 101710163270 Nuclease Proteins 0.000 description 29
• 210000001266 CD8-positive T-lymphocyte Anatomy 0.000 description 28
• 238000001994 activation Methods 0.000 description 28
• 230000004913 activation Effects 0.000 description 27
• 235000001014 amino acid Nutrition 0.000 description 27
• 230000004927 fusion Effects 0.000 description 26
• 125000003275 alpha amino acid group Chemical group 0.000 description 23
• 229940024606 amino acid Drugs 0.000 description 21
• 239000012636 effector Substances 0.000 description 21
• 210000000987 immune system Anatomy 0.000 description 21
• 239000003446 ligand Substances 0.000 description 21
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 20
• 108020004414 DNA Proteins 0.000 description 19
• 230000006870 function Effects 0.000 description 18
• 108700018351 Major Histocompatibility Complex Proteins 0.000 description 17
• 108091008874 T cell receptors Proteins 0.000 description 17
• 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 17
• 108020004705 Codon Proteins 0.000 description 15
• 102000000588 Interleukin-2 Human genes 0.000 description 15
• 102100040247 Tumor necrosis factor Human genes 0.000 description 15
• 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 15
• 108091033409 CRISPR Proteins 0.000 description 14
• 125000000539 amino acid group Chemical group 0.000 description 14
• 230000004069 differentiation Effects 0.000 description 14
• 210000004698 lymphocyte Anatomy 0.000 description 14
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 13
• 210000003071 memory t lymphocyte Anatomy 0.000 description 13
• 102100038222 60 kDa heat shock protein, mitochondrial Human genes 0.000 description 12
• 108010029697 CD40 Ligand Proteins 0.000 description 12
• 102100032937 CD40 ligand Human genes 0.000 description 12
• 101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 description 12
• 101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 description 12
• 102100027268 Interferon-stimulated gene 20 kDa protein Human genes 0.000 description 12
• 108091028043 Nucleic acid sequence Proteins 0.000 description 12
• 238000010362 genome editing Methods 0.000 description 12
• 230000003993 interaction Effects 0.000 description 12
• 230000008569 process Effects 0.000 description 12
• 230000004936 stimulating effect Effects 0.000 description 12
• 238000003776 cleavage reaction Methods 0.000 description 11
• 210000003958 hematopoietic stem cell Anatomy 0.000 description 11
• 230000007017 scission Effects 0.000 description 11
• 102000003814 Interleukin-10 Human genes 0.000 description 10
• 108090000174 Interleukin-10 Proteins 0.000 description 10
• 230000004075 alteration Effects 0.000 description 10
• 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 10
• 239000000047 product Substances 0.000 description 10
• 238000006467 substitution reaction Methods 0.000 description 10
• 108020005004 Guide RNA Proteins 0.000 description 9
• 230000001419 dependent effect Effects 0.000 description 9
• 239000000203 mixture Substances 0.000 description 9
• 230000037361 pathway Effects 0.000 description 9
• 230000000638 stimulation Effects 0.000 description 9
• 208000024891 symptom Diseases 0.000 description 9
• 102000019034 Chemokines Human genes 0.000 description 8
• 108010012236 Chemokines Proteins 0.000 description 8
• 230000001965 increasing effect Effects 0.000 description 8
• 229940076144 interleukin-10 Drugs 0.000 description 8
• 230000007246 mechanism Effects 0.000 description 8
• 108010082808 4-1BB Ligand Proteins 0.000 description 7
• 102000002627 4-1BB Ligand Human genes 0.000 description 7
• 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 7
• 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 7
• 108010074328 Interferon-gamma Proteins 0.000 description 7
• 102000008070 Interferon-gamma Human genes 0.000 description 7
• 210000004369 blood Anatomy 0.000 description 7
• 239000008280 blood Substances 0.000 description 7
• 238000006243 chemical reaction Methods 0.000 description 7
• 238000012217 deletion Methods 0.000 description 7
• 230000037430 deletion Effects 0.000 description 7
• 238000011161 development Methods 0.000 description 7
• 230000018109 developmental process Effects 0.000 description 7
• 210000002443 helper t lymphocyte Anatomy 0.000 description 7
• 229960003130 interferon gamma Drugs 0.000 description 7
• 230000000670 limiting effect Effects 0.000 description 7
• 230000004048 modification Effects 0.000 description 7
• 238000012986 modification Methods 0.000 description 7
• 210000001616 monocyte Anatomy 0.000 description 7
• 230000001629 suppression Effects 0.000 description 7
• 238000011282 treatment Methods 0.000 description 7
• 238000010453 CRISPR/Cas method Methods 0.000 description 6
• 108700010070 Codon Usage Proteins 0.000 description 6
• 208000035473 Communicable disease Diseases 0.000 description 6
• 102000004388 Interleukin-4 Human genes 0.000 description 6
• 108090000978 Interleukin-4 Proteins 0.000 description 6
• XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 6
• 230000010261 cell growth Effects 0.000 description 6
• 239000000306 component Substances 0.000 description 6
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 6
• 235000018417 cysteine Nutrition 0.000 description 6
• 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 6
• 208000015181 infectious disease Diseases 0.000 description 6
• 230000003834 intracellular effect Effects 0.000 description 6
• 239000000463 material Substances 0.000 description 6
• 108020004999 messenger RNA Proteins 0.000 description 6
• 230000028327 secretion Effects 0.000 description 6
• 230000001225 therapeutic effect Effects 0.000 description 6
• 210000001519 tissue Anatomy 0.000 description 6
• 238000013518 transcription Methods 0.000 description 6
• 230000035897 transcription Effects 0.000 description 6
• 230000003844 B-cell-activation Effects 0.000 description 5
• 108010042407 Endonucleases Proteins 0.000 description 5
• 108700024394 Exon Proteins 0.000 description 5
• 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 description 5
• 108060003951 Immunoglobulin Proteins 0.000 description 5
• 102000014150 Interferons Human genes 0.000 description 5
• 108010050904 Interferons Proteins 0.000 description 5
• 102000004889 Interleukin-6 Human genes 0.000 description 5
• 108090001005 Interleukin-6 Proteins 0.000 description 5
• 102000001708 Protein Isoforms Human genes 0.000 description 5
• 108091027544 Subgenomic mRNA Proteins 0.000 description 5
• 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 description 5
• 238000010459 TALEN Methods 0.000 description 5
• 238000003556 assay Methods 0.000 description 5
• 230000015572 biosynthetic process Effects 0.000 description 5
• 210000004899 c-terminal region Anatomy 0.000 description 5
• 230000003197 catalytic effect Effects 0.000 description 5
• 230000036755 cellular response Effects 0.000 description 5
• 239000003795 chemical substances by application Substances 0.000 description 5
• 230000000295 complement effect Effects 0.000 description 5
• 102000003675 cytokine receptors Human genes 0.000 description 5
• 108010057085 cytokine receptors Proteins 0.000 description 5
• 230000009089 cytolysis Effects 0.000 description 5
• 230000034431 double-strand break repair via homologous recombination Effects 0.000 description 5
• 102000018358 immunoglobulin Human genes 0.000 description 5
• 230000006698 induction Effects 0.000 description 5
• 229940028885 interleukin-4 Drugs 0.000 description 5
• 210000003643 myeloid progenitor cell Anatomy 0.000 description 5
• 230000006780 non-homologous end joining Effects 0.000 description 5
• 239000002773 nucleotide Substances 0.000 description 5
• 125000003729 nucleotide group Chemical group 0.000 description 5
• 230000026731 phosphorylation Effects 0.000 description 5
• 238000006366 phosphorylation reaction Methods 0.000 description 5
• 239000013612 plasmid Substances 0.000 description 5
• 230000004044 response Effects 0.000 description 5
• 230000019491 signal transduction Effects 0.000 description 5
• 230000008685 targeting Effects 0.000 description 5
• 230000014616 translation Effects 0.000 description 5
• 238000013519 translation Methods 0.000 description 5
• 101710155857 C-C motif chemokine 2 Proteins 0.000 description 4
• 102100021943 C-C motif chemokine 2 Human genes 0.000 description 4
• 102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 description 4
• 108050005493 CD3 protein, epsilon/gamma/delta subunit Proteins 0.000 description 4
• 108091026890 Coding region Proteins 0.000 description 4
• 102000053602 DNA Human genes 0.000 description 4
• 102000004190 Enzymes Human genes 0.000 description 4
• 108090000790 Enzymes Proteins 0.000 description 4
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
• 101001018097 Homo sapiens L-selectin Proteins 0.000 description 4
• 102100039897 Interleukin-5 Human genes 0.000 description 4
• 108010002616 Interleukin-5 Proteins 0.000 description 4
• 102100033467 L-selectin Human genes 0.000 description 4
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 4
• 102000018697 Membrane Proteins Human genes 0.000 description 4
• 108010052285 Membrane Proteins Proteins 0.000 description 4
• 206010028980 Neoplasm Diseases 0.000 description 4
• 102100024216 Programmed cell death 1 ligand 1 Human genes 0.000 description 4
• 108010029485 Protein Isoforms Proteins 0.000 description 4
• 108020004566 Transfer RNA Proteins 0.000 description 4
• 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 4
• 238000007792 addition Methods 0.000 description 4
• 235000004279 alanine Nutrition 0.000 description 4
• 230000006907 apoptotic process Effects 0.000 description 4
• 239000002585 base Substances 0.000 description 4
• 239000011324 bead Substances 0.000 description 4
• 102000015736 beta 2-Microglobulin Human genes 0.000 description 4
• 108010081355 beta 2-Microglobulin Proteins 0.000 description 4
• 239000012472 biological sample Substances 0.000 description 4
• 210000000170 cell membrane Anatomy 0.000 description 4
• 230000004663 cell proliferation Effects 0.000 description 4
• 210000005220 cytoplasmic tail Anatomy 0.000 description 4
• 239000000539 dimer Substances 0.000 description 4
• 229940088598 enzyme Drugs 0.000 description 4
• 238000010353 genetic engineering Methods 0.000 description 4
• 230000005931 immune cell recruitment Effects 0.000 description 4
• 230000001939 inductive effect Effects 0.000 description 4
• 238000003780 insertion Methods 0.000 description 4
• 230000037431 insertion Effects 0.000 description 4
• 229940100602 interleukin-5 Drugs 0.000 description 4
• 229940100601 interleukin-6 Drugs 0.000 description 4
• 210000004940 nucleus Anatomy 0.000 description 4
• 238000005457 optimization Methods 0.000 description 4
• 210000003491 skin Anatomy 0.000 description 4
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 4
• 239000004475 Arginine Substances 0.000 description 3
• 108091008875 B cell receptors Proteins 0.000 description 3
• 102100029822 B- and T-lymphocyte attenuator Human genes 0.000 description 3
• 241000894006 Bacteria Species 0.000 description 3
• 102100036301 C-C chemokine receptor type 7 Human genes 0.000 description 3
• 102100036008 CD48 antigen Human genes 0.000 description 3
• 230000007018 DNA scission Effects 0.000 description 3
• 102220577243 Density-regulated protein_Y84W_mutation Human genes 0.000 description 3
• 102100031780 Endonuclease Human genes 0.000 description 3
• 102000003886 Glycoproteins Human genes 0.000 description 3
• 108090000288 Glycoproteins Proteins 0.000 description 3
• 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 3
• 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 3
• 241000282412 Homo Species 0.000 description 3
• 101000716065 Homo sapiens C-C chemokine receptor type 7 Proteins 0.000 description 3
• 101100005713 Homo sapiens CD4 gene Proteins 0.000 description 3
• 101000716130 Homo sapiens CD48 antigen Proteins 0.000 description 3
• 101001063392 Homo sapiens Lymphocyte function-associated antigen 3 Proteins 0.000 description 3
• 101000669511 Homo sapiens T-cell immunoglobulin and mucin domain-containing protein 4 Proteins 0.000 description 3
• 102000000589 Interleukin-1 Human genes 0.000 description 3
• 108010002352 Interleukin-1 Proteins 0.000 description 3
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 3
• 102100030984 Lymphocyte function-associated antigen 3 Human genes 0.000 description 3
• 102000004083 Lymphotoxin-alpha Human genes 0.000 description 3
• 108090000542 Lymphotoxin-alpha Proteins 0.000 description 3
• 102100029740 Poliovirus receptor Human genes 0.000 description 3
• 108010076504 Protein Sorting Signals Proteins 0.000 description 3
• 102000008115 Signaling Lymphocytic Activation Molecule Family Member 1 Human genes 0.000 description 3
• 108010074687 Signaling Lymphocytic Activation Molecule Family Member 1 Proteins 0.000 description 3
• 230000017274 T cell anergy Effects 0.000 description 3
• 102100039367 T-cell immunoglobulin and mucin domain-containing protein 4 Human genes 0.000 description 3
• 102000040945 Transcription factor Human genes 0.000 description 3
• 108091023040 Transcription factor Proteins 0.000 description 3
• 241000700605 Viruses Species 0.000 description 3
• 210000000628 antibody-producing cell Anatomy 0.000 description 3
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
• 235000009697 arginine Nutrition 0.000 description 3
• 230000006399 behavior Effects 0.000 description 3
• 230000009286 beneficial effect Effects 0.000 description 3
• 230000008901 benefit Effects 0.000 description 3
• 210000002960 bfu-e Anatomy 0.000 description 3
• 230000008827 biological function Effects 0.000 description 3
• 238000004422 calculation algorithm Methods 0.000 description 3
• 201000011510 cancer Diseases 0.000 description 3
• 230000011712 cell development Effects 0.000 description 3
• 230000024245 cell differentiation Effects 0.000 description 3
• 238000012650 click reaction Methods 0.000 description 3
• 230000021615 conjugation Effects 0.000 description 3
• 230000006378 damage Effects 0.000 description 3
• 230000002255 enzymatic effect Effects 0.000 description 3
• 239000013604 expression vector Substances 0.000 description 3
• 230000013595 glycosylation Effects 0.000 description 3
• 238000006206 glycosylation reaction Methods 0.000 description 3
• 230000012010 growth Effects 0.000 description 3
• 230000036039 immunity Effects 0.000 description 3
• 108091008042 inhibitory receptors Proteins 0.000 description 3
• 229940079322 interferon Drugs 0.000 description 3
• 210000004962 mammalian cell Anatomy 0.000 description 3
• 230000003641 microbiacidal effect Effects 0.000 description 3
• 230000035772 mutation Effects 0.000 description 3
• 244000052769 pathogen Species 0.000 description 3
• 230000001717 pathogenic effect Effects 0.000 description 3
• 108010048507 poliovirus receptor Proteins 0.000 description 3
• 238000003752 polymerase chain reaction Methods 0.000 description 3
• 230000008439 repair process Effects 0.000 description 3
• 238000011160 research Methods 0.000 description 3
• 230000000717 retained effect Effects 0.000 description 3
• 230000007781 signaling event Effects 0.000 description 3
• 239000000126 substance Substances 0.000 description 3
• 230000002103 transcriptional effect Effects 0.000 description 3
• 238000001262 western blot Methods 0.000 description 3
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
• HVAUUPRFYPCOCA-AREMUKBSSA-N 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCOC[C@@H](OC(C)=O)COP([O-])(=O)OCC[N+](C)(C)C HVAUUPRFYPCOCA-AREMUKBSSA-N 0.000 description 2
• 230000005730 ADP ribosylation Effects 0.000 description 2
• 206010002556 Ankylosing Spondylitis Diseases 0.000 description 2
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 2
• 102100025221 CD70 antigen Human genes 0.000 description 2
• 102100035793 CD83 antigen Human genes 0.000 description 2
• 238000010446 CRISPR interference Methods 0.000 description 2
• 102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 description 2
• 230000004568 DNA-binding Effects 0.000 description 2
• 108010008532 Deoxyribonuclease I Proteins 0.000 description 2
• 102000007260 Deoxyribonuclease I Human genes 0.000 description 2
• 102000004533 Endonucleases Human genes 0.000 description 2
• 102000004862 Gastrin releasing peptide Human genes 0.000 description 2
• 108090001053 Gastrin releasing peptide Proteins 0.000 description 2
• 239000004471 Glycine Substances 0.000 description 2
• 101710197836 HLA class I histocompatibility antigen, alpha chain G Proteins 0.000 description 2
• 102100034458 Hepatitis A virus cellular receptor 2 Human genes 0.000 description 2
• 102000008949 Histocompatibility Antigens Class I Human genes 0.000 description 2
• 108010088652 Histocompatibility Antigens Class I Proteins 0.000 description 2
• 101000864344 Homo sapiens B- and T-lymphocyte attenuator Proteins 0.000 description 2
• 101000934356 Homo sapiens CD70 antigen Proteins 0.000 description 2
• 101000946856 Homo sapiens CD83 antigen Proteins 0.000 description 2
• 101000889276 Homo sapiens Cytotoxic T-lymphocyte protein 4 Proteins 0.000 description 2
• 101001068133 Homo sapiens Hepatitis A virus cellular receptor 2 Proteins 0.000 description 2
• 101001137987 Homo sapiens Lymphocyte activation gene 3 protein Proteins 0.000 description 2
• 101001117317 Homo sapiens Programmed cell death 1 ligand 1 Proteins 0.000 description 2
• 102100025390 Integrin beta-2 Human genes 0.000 description 2
• 102000003996 Interferon-beta Human genes 0.000 description 2
• 108090000467 Interferon-beta Proteins 0.000 description 2
• 108010065805 Interleukin-12 Proteins 0.000 description 2
• 102000013462 Interleukin-12 Human genes 0.000 description 2
• 108010038453 Interleukin-2 Receptors Proteins 0.000 description 2
• 102000010789 Interleukin-2 Receptors Human genes 0.000 description 2
• 102100021592 Interleukin-7 Human genes 0.000 description 2
• 108010002586 Interleukin-7 Proteins 0.000 description 2
• 102000004890 Interleukin-8 Human genes 0.000 description 2
• 108090001007 Interleukin-8 Proteins 0.000 description 2
• 102000015696 Interleukins Human genes 0.000 description 2
• 108010063738 Interleukins Proteins 0.000 description 2
• 208000003456 Juvenile Arthritis Diseases 0.000 description 2
• 206010059176 Juvenile idiopathic arthritis Diseases 0.000 description 2
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
• COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
• 102000017578 LAG3 Human genes 0.000 description 2
• 108010064548 Lymphocyte Function-Associated Antigen-1 Proteins 0.000 description 2
• 102000007651 Macrophage Colony-Stimulating Factor Human genes 0.000 description 2
• 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 description 2
• 241000124008 Mammalia Species 0.000 description 2
• 241001465754 Metazoa Species 0.000 description 2
• 241000713869 Moloney murine leukemia virus Species 0.000 description 2
• 241001529936 Murinae Species 0.000 description 2
• 101000597780 Mus musculus Tumor necrosis factor ligand superfamily member 18 Proteins 0.000 description 2
• 241000699670 Mus sp. Species 0.000 description 2
• 102100035488 Nectin-2 Human genes 0.000 description 2
• MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
• 208000034967 Non-Radiographic Axial Spondyloarthritis Diseases 0.000 description 2
• 108700026244 Open Reading Frames Proteins 0.000 description 2
• 108010003541 Platelet Activating Factor Proteins 0.000 description 2
• 108020004511 Recombinant DNA Proteins 0.000 description 2
• 241000283984 Rodentia Species 0.000 description 2
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
• 238000002105 Southern blotting Methods 0.000 description 2
• 108010090804 Streptavidin Proteins 0.000 description 2
• 230000024932 T cell mediated immunity Effects 0.000 description 2
• 102000002689 Toll-like receptor Human genes 0.000 description 2
• 108020000411 Toll-like receptor Proteins 0.000 description 2
• 102100024587 Tumor necrosis factor ligand superfamily member 15 Human genes 0.000 description 2
• 102100035283 Tumor necrosis factor ligand superfamily member 18 Human genes 0.000 description 2
• 102100031988 Tumor necrosis factor ligand superfamily member 6 Human genes 0.000 description 2
• 108050002568 Tumor necrosis factor ligand superfamily member 6 Proteins 0.000 description 2
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
• 230000033289 adaptive immune response Effects 0.000 description 2
• 238000004458 analytical method Methods 0.000 description 2
• 230000030741 antigen processing and presentation Effects 0.000 description 2
• 238000013459 approach Methods 0.000 description 2
• 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 2
• 235000009582 asparagine Nutrition 0.000 description 2
• 229960001230 asparagine Drugs 0.000 description 2
• 230000005784 autoimmunity Effects 0.000 description 2
• 230000033228 biological regulation Effects 0.000 description 2
• 210000001185 bone marrow Anatomy 0.000 description 2
• 230000032823 cell division Effects 0.000 description 2
• 210000001175 cerebrospinal fluid Anatomy 0.000 description 2
• 239000003153 chemical reaction reagent Substances 0.000 description 2
• 238000010367 cloning Methods 0.000 description 2
• 230000001332 colony forming effect Effects 0.000 description 2
• 230000008878 coupling Effects 0.000 description 2
• 238000010168 coupling process Methods 0.000 description 2
• 238000005859 coupling reaction Methods 0.000 description 2
• 230000001086 cytosolic effect Effects 0.000 description 2
• 230000007423 decrease Effects 0.000 description 2
• 238000003745 diagnosis Methods 0.000 description 2
• 238000009826 distribution Methods 0.000 description 2
• 230000003828 downregulation Effects 0.000 description 2
• 239000003814 drug Substances 0.000 description 2
• 239000003937 drug carrier Substances 0.000 description 2
• 230000008030 elimination Effects 0.000 description 2
• 238000003379 elimination reaction Methods 0.000 description 2
• 230000010437 erythropoiesis Effects 0.000 description 2
• 230000006251 gamma-carboxylation Effects 0.000 description 2
• PUBCCFNQJQKCNC-XKNFJVFFSA-N gastrin-releasingpeptide Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)C1=CNC=N1 PUBCCFNQJQKCNC-XKNFJVFFSA-N 0.000 description 2
• 231100000118 genetic alteration Toxicity 0.000 description 2
• 230000004077 genetic alteration Effects 0.000 description 2
• 230000037442 genomic alteration Effects 0.000 description 2
• 239000003102 growth factor Substances 0.000 description 2
• 230000003394 haemopoietic effect Effects 0.000 description 2
• 230000036541 health Effects 0.000 description 2
• 239000000833 heterodimer Substances 0.000 description 2
• 210000005260 human cell Anatomy 0.000 description 2
• 230000033444 hydroxylation Effects 0.000 description 2
• 238000005805 hydroxylation reaction Methods 0.000 description 2
• 230000016784 immunoglobulin production Effects 0.000 description 2
• 230000000415 inactivating effect Effects 0.000 description 2
• 210000004263 induced pluripotent stem cell Anatomy 0.000 description 2
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
• 229960001388 interferon-beta Drugs 0.000 description 2
• 229940047124 interferons Drugs 0.000 description 2
• 229940117681 interleukin-12 Drugs 0.000 description 2
• 229940100994 interleukin-7 Drugs 0.000 description 2
• 229940096397 interleukin-8 Drugs 0.000 description 2
• XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(C)=O)CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N1[C@H](CCC1)C(=O)N1[C@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC(O)=CC=1)C(=O)N[C@H](CO)C(=O)N1[C@H](CCC1)C(N)=O)C1=CC=CC=C1 XKTZWUACRZHVAN-VADRZIEHSA-N 0.000 description 2
• 210000004005 intermediate erythroblast Anatomy 0.000 description 2
• 201000002215 juvenile rheumatoid arthritis Diseases 0.000 description 2
• 230000002147 killing effect Effects 0.000 description 2
• 150000002632 lipids Chemical class 0.000 description 2
• 210000002751 lymph Anatomy 0.000 description 2
• 210000005210 lymphoid organ Anatomy 0.000 description 2
• 210000003563 lymphoid tissue Anatomy 0.000 description 2
• 230000002934 lysing effect Effects 0.000 description 2
• 230000002132 lysosomal effect Effects 0.000 description 2
• 239000003550 marker Substances 0.000 description 2
• 230000035800 maturation Effects 0.000 description 2
• 210000000135 megakaryocyte-erythroid progenitor cell Anatomy 0.000 description 2
• 210000002901 mesenchymal stem cell Anatomy 0.000 description 2
• 239000011325 microbead Substances 0.000 description 2
• 244000005700 microbiome Species 0.000 description 2
• 210000003924 normoblast Anatomy 0.000 description 2
• 210000000056 organ Anatomy 0.000 description 2
• 230000002093 peripheral effect Effects 0.000 description 2
• 239000000546 pharmaceutical excipient Substances 0.000 description 2
• 230000000144 pharmacologic effect Effects 0.000 description 2
• COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
• 229920000642 polymer Polymers 0.000 description 2
• 230000018491 positive regulation of cytokine secretion Effects 0.000 description 2
• 230000004481 post-translational protein modification Effects 0.000 description 2
• 230000003389 potentiating effect Effects 0.000 description 2
• 238000002360 preparation method Methods 0.000 description 2
• 238000011321 prophylaxis Methods 0.000 description 2
• 230000003134 recirculating effect Effects 0.000 description 2
• 230000006798 recombination Effects 0.000 description 2
• 238000005215 recombination Methods 0.000 description 2
• 230000009467 reduction Effects 0.000 description 2
• 230000009711 regulatory function Effects 0.000 description 2
• 230000028617 response to DNA damage stimulus Effects 0.000 description 2
• 238000012552 review Methods 0.000 description 2
• 230000011664 signaling Effects 0.000 description 2
• 239000002904 solvent Substances 0.000 description 2
• 239000000758 substrate Substances 0.000 description 2
• 230000019635 sulfation Effects 0.000 description 2
• 238000005670 sulfation reaction Methods 0.000 description 2
• 230000004083 survival effect Effects 0.000 description 2
• 230000002123 temporal effect Effects 0.000 description 2
• 238000012360 testing method Methods 0.000 description 2
• 238000002560 therapeutic procedure Methods 0.000 description 2
• 210000001541 thymus gland Anatomy 0.000 description 2
• 231100000331 toxic Toxicity 0.000 description 2
• 230000002588 toxic effect Effects 0.000 description 2
• 230000032258 transport Effects 0.000 description 2
• 230000034512 ubiquitination Effects 0.000 description 2
• 238000010798 ubiquitination Methods 0.000 description 2
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
• 229910052725 zinc Inorganic materials 0.000 description 2
• 239000011701 zinc Substances 0.000 description 2
• 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
• ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 description 1
• KISWVXRQTGLFGD-UHFFFAOYSA-N 2-[[2-[[6-amino-2-[[2-[[2-[[5-amino-2-[[2-[[1-[2-[[6-amino-2-[(2,5-diamino-5-oxopentanoyl)amino]hexanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-(diaminomethylideneamino)p Chemical compound C1CCN(C(=O)C(CCCN=C(N)N)NC(=O)C(CCCCN)NC(=O)C(N)CCC(N)=O)C1C(=O)NC(CO)C(=O)NC(CCC(N)=O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(C(=O)NC(CC(C)C)C(O)=O)CC1=CC=C(O)C=C1 KISWVXRQTGLFGD-UHFFFAOYSA-N 0.000 description 1
• ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
• 102100023990 60S ribosomal protein L17 Human genes 0.000 description 1
• 102100026882 Alpha-synuclein Human genes 0.000 description 1
• 108090001008 Avidin Proteins 0.000 description 1
• 208000025705 Axial Spondyloarthritis Diseases 0.000 description 1
• 101710144268 B- and T-lymphocyte attenuator Proteins 0.000 description 1
• 102100035634 B-cell linker protein Human genes 0.000 description 1
• 102100032367 C-C motif chemokine 5 Human genes 0.000 description 1
• 102100032366 C-C motif chemokine 7 Human genes 0.000 description 1
• 101710155834 C-C motif chemokine 7 Proteins 0.000 description 1
• 102100036150 C-X-C motif chemokine 5 Human genes 0.000 description 1
• 102100036153 C-X-C motif chemokine 6 Human genes 0.000 description 1
• 101710085504 C-X-C motif chemokine 6 Proteins 0.000 description 1
• 102000001902 CC Chemokines Human genes 0.000 description 1
• 108010040471 CC Chemokines Proteins 0.000 description 1
• 102100024263 CD160 antigen Human genes 0.000 description 1
• 108050006947 CXC Chemokine Proteins 0.000 description 1
• 102000019388 CXC chemokine Human genes 0.000 description 1
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
• 102000000844 Cell Surface Receptors Human genes 0.000 description 1
• 108010001857 Cell Surface Receptors Proteins 0.000 description 1
• 102100025064 Cellular tumor antigen p53 Human genes 0.000 description 1
• 108010055166 Chemokine CCL5 Proteins 0.000 description 1
• 108020004638 Circular DNA Proteins 0.000 description 1
• 206010009900 Colitis ulcerative Diseases 0.000 description 1
• 108010035532 Collagen Proteins 0.000 description 1
• 102000008186 Collagen Human genes 0.000 description 1
• 208000011231 Crohn disease Diseases 0.000 description 1
• 102220605874 Cytosolic arginine sensor for mTORC1 subunit 2_D10A_mutation Human genes 0.000 description 1
• 230000005971 DNA damage repair Effects 0.000 description 1
• 230000008836 DNA modification Effects 0.000 description 1
• 101710150423 DNA nickase Proteins 0.000 description 1
• 101100239628 Danio rerio myca gene Proteins 0.000 description 1
• 238000012286 ELISA Assay Methods 0.000 description 1
• 238000011510 Elispot assay Methods 0.000 description 1
• 102100023688 Eotaxin Human genes 0.000 description 1
• 101710139422 Eotaxin Proteins 0.000 description 1
• 108090000852 Forkhead Transcription Factors Proteins 0.000 description 1
• 102100027581 Forkhead box protein P3 Human genes 0.000 description 1
• 101710115997 Gamma-tubulin complex component 2 Proteins 0.000 description 1
• 206010018364 Glomerulonephritis Diseases 0.000 description 1
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
• 102000028180 Glycophorins Human genes 0.000 description 1
• 201000005569 Gout Diseases 0.000 description 1
• 206010018634 Gouty Arthritis Diseases 0.000 description 1
• 102000001398 Granzyme Human genes 0.000 description 1
• 108060005986 Granzyme Proteins 0.000 description 1
• 102100034221 Growth-regulated alpha protein Human genes 0.000 description 1
• 101710197873 HLA class I histocompatibility antigen, alpha chain E Proteins 0.000 description 1
• 102000029812 HNH nuclease Human genes 0.000 description 1
• 108060003760 HNH nuclease Proteins 0.000 description 1
• 108010068250 Herpes Simplex Virus Protein Vmw65 Proteins 0.000 description 1
• SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
• 101000834898 Homo sapiens Alpha-synuclein Proteins 0.000 description 1
• 101000761938 Homo sapiens CD160 antigen Proteins 0.000 description 1
• 101100441523 Homo sapiens CXCL5 gene Proteins 0.000 description 1
• 101000861452 Homo sapiens Forkhead box protein P3 Proteins 0.000 description 1
• 101001069921 Homo sapiens Growth-regulated alpha protein Proteins 0.000 description 1
• 101001019455 Homo sapiens ICOS ligand Proteins 0.000 description 1
• 101000960954 Homo sapiens Interleukin-18 Proteins 0.000 description 1
• 101000984190 Homo sapiens Leukocyte immunoglobulin-like receptor subfamily B member 1 Proteins 0.000 description 1
• 101001138062 Homo sapiens Leukocyte-associated immunoglobulin-like receptor 1 Proteins 0.000 description 1
• 101000973997 Homo sapiens Nucleosome assembly protein 1-like 4 Proteins 0.000 description 1
• 101000947178 Homo sapiens Platelet basic protein Proteins 0.000 description 1
• 101000611936 Homo sapiens Programmed cell death protein 1 Proteins 0.000 description 1
• 101000652359 Homo sapiens Spermatogenesis-associated protein 2 Proteins 0.000 description 1
• 101000831007 Homo sapiens T-cell immunoreceptor with Ig and ITIM domains Proteins 0.000 description 1
• 101001102797 Homo sapiens Transmembrane protein PVRIG Proteins 0.000 description 1
• 101000830596 Homo sapiens Tumor necrosis factor ligand superfamily member 15 Proteins 0.000 description 1
• 101000801234 Homo sapiens Tumor necrosis factor receptor superfamily member 18 Proteins 0.000 description 1
• 101000666896 Homo sapiens V-type immunoglobulin domain-containing suppressor of T-cell activation Proteins 0.000 description 1
• 241000701044 Human gammaherpesvirus 4 Species 0.000 description 1
• 241000725303 Human immunodeficiency virus Species 0.000 description 1
• 241000701806 Human papillomavirus Species 0.000 description 1
• LCWXJXMHJVIJFK-UHFFFAOYSA-N Hydroxylysine Chemical group NCC(O)CC(N)CC(O)=O LCWXJXMHJVIJFK-UHFFFAOYSA-N 0.000 description 1
• 102100034980 ICOS ligand Human genes 0.000 description 1
• 230000006133 ISGylation Effects 0.000 description 1
• 102000004877 Insulin Human genes 0.000 description 1
• 108090001061 Insulin Proteins 0.000 description 1
• 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 description 1
• 102100037877 Intercellular adhesion molecule 1 Human genes 0.000 description 1
• 102000006992 Interferon-alpha Human genes 0.000 description 1
• 108010047761 Interferon-alpha Proteins 0.000 description 1
• 108091029795 Intergenic region Proteins 0.000 description 1
• 102100039898 Interleukin-18 Human genes 0.000 description 1
• 108010017411 Interleukin-21 Receptors Proteins 0.000 description 1
• 102100030699 Interleukin-21 receptor Human genes 0.000 description 1
• 102100039064 Interleukin-3 Human genes 0.000 description 1
• 108010002386 Interleukin-3 Proteins 0.000 description 1
• 108700021430 Kruppel-Like Factor 4 Proteins 0.000 description 1
• ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
• AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
• FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
• AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical group C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical group C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
• KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
• 108090001090 Lectins Proteins 0.000 description 1
• 102000004856 Lectins Human genes 0.000 description 1
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
• 102100025584 Leukocyte immunoglobulin-like receptor subfamily B member 1 Human genes 0.000 description 1
• 102100020943 Leukocyte-associated immunoglobulin-like receptor 1 Human genes 0.000 description 1
• 102000008072 Lymphokines Human genes 0.000 description 1
• 108010074338 Lymphokines Proteins 0.000 description 1
• 102100035304 Lymphotactin Human genes 0.000 description 1
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
• 239000004472 Lysine Substances 0.000 description 1
• 108700005089 MHC Class I Genes Proteins 0.000 description 1
• 108010061593 Member 14 Tumor Necrosis Factor Receptors Proteins 0.000 description 1
• 102000014962 Monocyte Chemoattractant Proteins Human genes 0.000 description 1
• 108010064136 Monocyte Chemoattractant Proteins Proteins 0.000 description 1
• 241000699666 Mus <mouse, genus> Species 0.000 description 1
• 101100181099 Mus musculus Klra1 gene Proteins 0.000 description 1
• 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
• 102000047918 Myelin Basic Human genes 0.000 description 1
• 101710107068 Myelin basic protein Proteins 0.000 description 1
• 230000006181 N-acylation Effects 0.000 description 1
• 230000004988 N-glycosylation Effects 0.000 description 1
• 241000588653 Neisseria Species 0.000 description 1
• 108020004485 Nonsense Codon Proteins 0.000 description 1
• 230000006179 O-acylation Effects 0.000 description 1
• 230000004989 O-glycosylation Effects 0.000 description 1
• 108091034117 Oligonucleotide Proteins 0.000 description 1
• 229910019142 PO4 Inorganic materials 0.000 description 1
• 101710126211 POU domain, class 5, transcription factor 1 Proteins 0.000 description 1
• 102000035195 Peptidases Human genes 0.000 description 1
• 108091005804 Peptidases Proteins 0.000 description 1
• KHGNFPUMBJSZSM-UHFFFAOYSA-N Perforine Natural products COC1=C2CCC(O)C(CCC(C)(C)O)(OC)C2=NC2=C1C=CO2 KHGNFPUMBJSZSM-UHFFFAOYSA-N 0.000 description 1
• 108010064785 Phospholipases Proteins 0.000 description 1
• 102000015439 Phospholipases Human genes 0.000 description 1
• 101710112477 Phycobiliprotein ApcE Proteins 0.000 description 1
• 102100036154 Platelet basic protein Human genes 0.000 description 1
• 239000004793 Polystyrene Substances 0.000 description 1
• 108091000054 Prion Proteins 0.000 description 1
• 102000029797 Prion Human genes 0.000 description 1
• 101710089372 Programmed cell death protein 1 Proteins 0.000 description 1
• ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
• 102000003923 Protein Kinase C Human genes 0.000 description 1
• 108090000315 Protein Kinase C Proteins 0.000 description 1
• 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 1
• 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 1
• 201000004681 Psoriasis Diseases 0.000 description 1
• 201000001263 Psoriatic Arthritis Diseases 0.000 description 1
• 208000036824 Psoriatic arthropathy Diseases 0.000 description 1
• 101100247004 Rattus norvegicus Qsox1 gene Proteins 0.000 description 1
• 208000035415 Reinfection Diseases 0.000 description 1
• 108091028664 Ribonucleotide Proteins 0.000 description 1
• 230000006191 S-acylation Effects 0.000 description 1
• 230000006295 S-nitrosylation Effects 0.000 description 1
• 108020004682 Single-Stranded DNA Proteins 0.000 description 1
• 108020004459 Small interfering RNA Proteins 0.000 description 1
• 241000194017 Streptococcus Species 0.000 description 1
• 241000193996 Streptococcus pyogenes Species 0.000 description 1
• 208000018359 Systemic autoimmune disease Diseases 0.000 description 1
• 230000006044 T cell activation Effects 0.000 description 1
• 230000006052 T cell proliferation Effects 0.000 description 1
• 102100024834 T-cell immunoreceptor with Ig and ITIM domains Human genes 0.000 description 1
• 210000000662 T-lymphocyte subset Anatomy 0.000 description 1
• 210000004241 Th2 cell Anatomy 0.000 description 1
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Chemical group CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
• 239000004473 Threonine Chemical group 0.000 description 1
• 108010073062 Transcription Activator-Like Effectors Proteins 0.000 description 1
• 102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
• 108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
• 102100039630 Transmembrane protein PVRIG Human genes 0.000 description 1
• 206010052779 Transplant rejections Diseases 0.000 description 1
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Chemical group C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
• 108010078814 Tumor Suppressor Protein p53 Proteins 0.000 description 1
• 108090000138 Tumor necrosis factor ligand superfamily member 15 Proteins 0.000 description 1
• 102100028785 Tumor necrosis factor receptor superfamily member 14 Human genes 0.000 description 1
• 102100033728 Tumor necrosis factor receptor superfamily member 18 Human genes 0.000 description 1
• 201000006704 Ulcerative Colitis Diseases 0.000 description 1
• 102100038282 V-type immunoglobulin domain-containing suppressor of T-cell activation Human genes 0.000 description 1
• KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
• 241000589634 Xanthomonas Species 0.000 description 1
• 108010017070 Zinc Finger Nucleases Proteins 0.000 description 1
• PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
• 230000021736 acetylation Effects 0.000 description 1
• 238000006640 acetylation reaction Methods 0.000 description 1
• 210000004093 acidophilic erythroblast Anatomy 0.000 description 1
• 230000009471 action Effects 0.000 description 1
• 239000011149 active material Substances 0.000 description 1
• 239000013543 active substance Substances 0.000 description 1
• 208000038016 acute inflammation Diseases 0.000 description 1
• 230000006022 acute inflammation Effects 0.000 description 1
• 230000010933 acylation Effects 0.000 description 1
• 238000005917 acylation reaction Methods 0.000 description 1
• 210000005006 adaptive immune system Anatomy 0.000 description 1
• 102000035181 adaptor proteins Human genes 0.000 description 1
• 108091005764 adaptor proteins Proteins 0.000 description 1
• 230000006154 adenylylation Effects 0.000 description 1
• 150000001295 alanines Chemical class 0.000 description 1
• 150000001336 alkenes Chemical class 0.000 description 1
• 150000001345 alkine derivatives Chemical class 0.000 description 1
• 230000029936 alkylation Effects 0.000 description 1
• 238000005804 alkylation reaction Methods 0.000 description 1
• 230000000735 allogeneic effect Effects 0.000 description 1
• 230000009435 amidation Effects 0.000 description 1
• 238000007112 amidation reaction Methods 0.000 description 1
• 238000010171 animal model Methods 0.000 description 1
• 230000005875 antibody response Effects 0.000 description 1
• 235000003704 aspartic acid Nutrition 0.000 description 1
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
• 201000004982 autoimmune uveitis Diseases 0.000 description 1
• 150000001540 azides Chemical class 0.000 description 1
• 230000001580 bacterial effect Effects 0.000 description 1
• 244000052616 bacterial pathogen Species 0.000 description 1
• 210000003651 basophil Anatomy 0.000 description 1
• 210000004103 basophilic normoblast Anatomy 0.000 description 1
• 208000013404 behavioral symptom Diseases 0.000 description 1
• OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
• 210000000941 bile Anatomy 0.000 description 1
• 230000004071 biological effect Effects 0.000 description 1
• 239000013060 biological fluid Substances 0.000 description 1
• 239000012620 biological material Substances 0.000 description 1
• 235000020958 biotin Nutrition 0.000 description 1
• 239000011616 biotin Substances 0.000 description 1
• 229960002685 biotin Drugs 0.000 description 1
• 210000001109 blastomere Anatomy 0.000 description 1
• 238000009534 blood test Methods 0.000 description 1
• 210000004556 brain Anatomy 0.000 description 1
• 230000006242 butyrylation Effects 0.000 description 1
• 238000010514 butyrylation reaction Methods 0.000 description 1
• 239000006227 byproduct Substances 0.000 description 1
• 229910052791 calcium Inorganic materials 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• 230000021235 carbamoylation Effects 0.000 description 1
• 150000001720 carbohydrates Chemical class 0.000 description 1
• 235000014633 carbohydrates Nutrition 0.000 description 1
• 210000004970 cd4 cell Anatomy 0.000 description 1
• 230000030833 cell death Effects 0.000 description 1
• 230000003915 cell function Effects 0.000 description 1
• 239000002771 cell marker Substances 0.000 description 1
• 230000017455 cell-cell adhesion Effects 0.000 description 1
• 230000001413 cellular effect Effects 0.000 description 1
• 230000008614 cellular interaction Effects 0.000 description 1
• 230000030570 cellular localization Effects 0.000 description 1
• 230000008859 change Effects 0.000 description 1
• 238000007385 chemical modification Methods 0.000 description 1
• 239000007795 chemical reaction product Substances 0.000 description 1
• 239000002975 chemoattractant Substances 0.000 description 1
• 238000002512 chemotherapy Methods 0.000 description 1
• 239000013611 chromosomal DNA Substances 0.000 description 1
• 208000019069 chronic childhood arthritis Diseases 0.000 description 1
• 208000037976 chronic inflammation Diseases 0.000 description 1
• 230000006020 chronic inflammation Effects 0.000 description 1
• 230000006329 citrullination Effects 0.000 description 1
• 108091008033 coinhibitory receptors Proteins 0.000 description 1
• 229920001436 collagen Polymers 0.000 description 1
• 150000001875 compounds Chemical class 0.000 description 1
• 238000004590 computer program Methods 0.000 description 1
• 230000001276 controlling effect Effects 0.000 description 1
• 108091008034 costimulatory receptors Proteins 0.000 description 1
• 238000002425 crystallisation Methods 0.000 description 1
• 230000008025 crystallization Effects 0.000 description 1
• 230000003436 cytoskeletal effect Effects 0.000 description 1
• 230000003013 cytotoxicity Effects 0.000 description 1
• 231100000135 cytotoxicity Toxicity 0.000 description 1
• 230000006240 deamidation Effects 0.000 description 1
• 230000034994 death Effects 0.000 description 1
• 230000002950 deficient Effects 0.000 description 1
• 230000002939 deleterious effect Effects 0.000 description 1
• YSMODUONRAFBET-UHFFFAOYSA-N delta-DL-hydroxylysine Chemical group NCC(O)CCC(N)C(O)=O YSMODUONRAFBET-UHFFFAOYSA-N 0.000 description 1
• 239000005547 deoxyribonucleotide Substances 0.000 description 1
• 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
• 238000001514 detection method Methods 0.000 description 1
• 206010012601 diabetes mellitus Diseases 0.000 description 1
• 150000001993 dienes Chemical class 0.000 description 1
• FOOBQHKMWYGHCE-UHFFFAOYSA-N diphthamide Chemical compound C[N+](C)(C)C(C(N)=O)CCC1=NC=C(CC(N)C([O-])=O)N1 FOOBQHKMWYGHCE-UHFFFAOYSA-N 0.000 description 1
• 238000004821 distillation Methods 0.000 description 1
• 230000006330 eliminylation Effects 0.000 description 1
• 230000002121 endocytic effect Effects 0.000 description 1
• 230000012202 endocytosis Effects 0.000 description 1
• 238000005516 engineering process Methods 0.000 description 1
• 230000002708 enhancing effect Effects 0.000 description 1
• 238000003114 enzyme-linked immunosorbent spot assay Methods 0.000 description 1
• 210000002919 epithelial cell Anatomy 0.000 description 1
• 230000008029 eradication Effects 0.000 description 1
• YSMODUONRAFBET-UHNVWZDZSA-N erythro-5-hydroxy-L-lysine Chemical group NC[C@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-UHNVWZDZSA-N 0.000 description 1
• 230000006163 ethanolamine phosphoglycerol attachment Effects 0.000 description 1
• 230000006203 ethylation Effects 0.000 description 1
• 238000006200 ethylation reaction Methods 0.000 description 1
• 210000003527 eukaryotic cell Anatomy 0.000 description 1
• 210000003722 extracellular fluid Anatomy 0.000 description 1
• 230000002550 fecal effect Effects 0.000 description 1
• 210000004700 fetal blood Anatomy 0.000 description 1
• 230000001605 fetal effect Effects 0.000 description 1
• FVTCRASFADXXNN-SCRDCRAPSA-N flavin mononucleotide Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-SCRDCRAPSA-N 0.000 description 1
• 125000004072 flavinyl group Chemical group 0.000 description 1
• 238000000684 flow cytometry Methods 0.000 description 1
• IJJVMEJXYNJXOJ-UHFFFAOYSA-N fluquinconazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1N1C(=O)C2=CC(F)=CC=C2N=C1N1C=NC=N1 IJJVMEJXYNJXOJ-UHFFFAOYSA-N 0.000 description 1
• 230000003325 follicular Effects 0.000 description 1
• 230000022244 formylation Effects 0.000 description 1
• 238000006170 formylation reaction Methods 0.000 description 1
• 231100000221 frame shift mutation induction Toxicity 0.000 description 1
• 230000037433 frameshift Effects 0.000 description 1
• 238000002825 functional assay Methods 0.000 description 1
• 239000000499 gel Substances 0.000 description 1
• 238000003209 gene knockout Methods 0.000 description 1
• 230000002068 genetic effect Effects 0.000 description 1
• 210000001102 germinal center b cell Anatomy 0.000 description 1
• 235000013922 glutamic acid Nutrition 0.000 description 1
• 239000004220 glutamic acid Substances 0.000 description 1
• 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 1
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
• 230000035430 glutathionylation Effects 0.000 description 1
• 125000003147 glycosyl group Chemical group 0.000 description 1
• 108010033706 glycylserine Proteins 0.000 description 1
• 230000006095 glypiation Effects 0.000 description 1
• 210000004209 hair Anatomy 0.000 description 1
• 230000006149 hemylation Effects 0.000 description 1
• 210000003630 histaminocyte Anatomy 0.000 description 1
• 230000002962 histologic effect Effects 0.000 description 1
• 230000013632 homeostatic process Effects 0.000 description 1
• 125000001165 hydrophobic group Chemical group 0.000 description 1
• QJHBJHUKURJDLG-UHFFFAOYSA-N hydroxy-L-lysine Chemical group NCCCCC(NO)C(O)=O QJHBJHUKURJDLG-UHFFFAOYSA-N 0.000 description 1
• 230000006164 hypusine formation Effects 0.000 description 1
• 230000006450 immune cell response Effects 0.000 description 1
• 230000036737 immune function Effects 0.000 description 1
• 230000008102 immune modulation Effects 0.000 description 1
• 230000006058 immune tolerance Effects 0.000 description 1
• 238000010820 immunofluorescence microscopy Methods 0.000 description 1
• 230000002998 immunogenetic effect Effects 0.000 description 1
• 230000004957 immunoregulator effect Effects 0.000 description 1
• 230000001024 immunotherapeutic effect Effects 0.000 description 1
• 230000001976 improved effect Effects 0.000 description 1
• 239000000411 inducer Substances 0.000 description 1
• 230000037456 inflammatory mechanism Effects 0.000 description 1
• 230000028709 inflammatory response Effects 0.000 description 1
• 239000003112 inhibitor Substances 0.000 description 1
• 230000000977 initiatory effect Effects 0.000 description 1
• 230000015788 innate immune response Effects 0.000 description 1
• 238000011081 inoculation Methods 0.000 description 1
• 229960000367 inositol Drugs 0.000 description 1
• 229940125396 insulin Drugs 0.000 description 1
• 229940047122 interleukins Drugs 0.000 description 1
• 239000000543 intermediate Substances 0.000 description 1
• 244000000056 intracellular parasite Species 0.000 description 1
• 230000026045 iodination Effects 0.000 description 1
• 238000006192 iodination reaction Methods 0.000 description 1
• AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
• 229960000310 isoleucine Drugs 0.000 description 1
• 230000006122 isoprenylation Effects 0.000 description 1
• 210000001821 langerhans cell Anatomy 0.000 description 1
• 239000004816 latex Substances 0.000 description 1
• 229920000126 latex Polymers 0.000 description 1
• 239000002523 lectin Substances 0.000 description 1
• VNYSSYRCGWBHLG-AMOLWHMGSA-M leukotriene B4(1-) Chemical compound CCCCC\C=C/C[C@@H](O)\C=C\C=C\C=C/[C@@H](O)CCCC([O-])=O VNYSSYRCGWBHLG-AMOLWHMGSA-M 0.000 description 1
• 230000006144 lipoylation Effects 0.000 description 1
• 230000033001 locomotion Effects 0.000 description 1
• 206010025135 lupus erythematosus Diseases 0.000 description 1
• 210000001165 lymph node Anatomy 0.000 description 1
• 108010019677 lymphotactin Proteins 0.000 description 1
• 238000002595 magnetic resonance imaging Methods 0.000 description 1
• 230000017538 malonylation Effects 0.000 description 1
• 210000003519 mature b lymphocyte Anatomy 0.000 description 1
• 210000001806 memory b lymphocyte Anatomy 0.000 description 1
• 230000037353 metabolic pathway Effects 0.000 description 1
• 229930182817 methionine Natural products 0.000 description 1
• 230000011987 methylation Effects 0.000 description 1
• 238000007069 methylation reaction Methods 0.000 description 1
• 239000011859 microparticle Substances 0.000 description 1
• 239000003226 mitogen Substances 0.000 description 1
• 238000010369 molecular cloning Methods 0.000 description 1
• 239000000178 monomer Substances 0.000 description 1
• 210000002864 mononuclear phagocyte Anatomy 0.000 description 1
• 238000001964 muscle biopsy Methods 0.000 description 1
• 230000004220 muscle function Effects 0.000 description 1
• 238000002703 mutagenesis Methods 0.000 description 1
• 231100000350 mutagenesis Toxicity 0.000 description 1
• 230000007498 myristoylation Effects 0.000 description 1
• 230000009527 neddylation Effects 0.000 description 1
• 231100000252 nontoxic Toxicity 0.000 description 1
• 230000003000 nontoxic effect Effects 0.000 description 1
• 230000005257 nucleotidylation Effects 0.000 description 1
• 201000008482 osteoarthritis Diseases 0.000 description 1
• 230000003647 oxidation Effects 0.000 description 1
• 238000007254 oxidation reaction Methods 0.000 description 1
• 229910052760 oxygen Inorganic materials 0.000 description 1
• 239000001301 oxygen Substances 0.000 description 1
• 230000026792 palmitoylation Effects 0.000 description 1
• 244000045947 parasite Species 0.000 description 1
• 230000024241 parasitism Effects 0.000 description 1
• 239000002245 particle Substances 0.000 description 1
• 230000001575 pathological effect Effects 0.000 description 1
• 230000007170 pathology Effects 0.000 description 1
• 238000010647 peptide synthesis reaction Methods 0.000 description 1
• 229930192851 perforin Natural products 0.000 description 1
• 230000000737 periodic effect Effects 0.000 description 1
• 229940124531 pharmaceutical excipient Drugs 0.000 description 1
• 239000010452 phosphate Substances 0.000 description 1
• 230000005261 phosphopantetheinylation Effects 0.000 description 1
• PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical compound NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 description 1
• 230000004962 physiological condition Effects 0.000 description 1
• 230000035790 physiological processes and functions Effects 0.000 description 1
• 230000003169 placental effect Effects 0.000 description 1
• 210000002381 plasma Anatomy 0.000 description 1
• 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 1
• 102000054765 polymorphisms of proteins Human genes 0.000 description 1
• 229920002223 polystyrene Polymers 0.000 description 1
• 230000023603 positive regulation of transcription initiation, DNA-dependent Effects 0.000 description 1
• 230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 description 1
• 230000001323 posttranslational effect Effects 0.000 description 1
• 230000013823 prenylation Effects 0.000 description 1
• 230000002265 prevention Effects 0.000 description 1
• 238000012545 processing Methods 0.000 description 1
• 102000003998 progesterone receptors Human genes 0.000 description 1
• 108090000468 progesterone receptors Proteins 0.000 description 1
• 230000002035 prolonged effect Effects 0.000 description 1
• 230000001737 promoting effect Effects 0.000 description 1
• 230000000644 propagated effect Effects 0.000 description 1
• 230000000069 prophylactic effect Effects 0.000 description 1
• 230000006289 propionylation Effects 0.000 description 1
• 238000010515 propionylation reaction Methods 0.000 description 1
• 108020001580 protein domains Proteins 0.000 description 1
• 230000004850 protein–protein interaction Effects 0.000 description 1
• 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
• 238000000746 purification Methods 0.000 description 1
• 229940043131 pyroglutamate Drugs 0.000 description 1
• 230000006340 racemization Effects 0.000 description 1
• ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 1
• 102000016914 ras Proteins Human genes 0.000 description 1
• 238000009877 rendering Methods 0.000 description 1
• 230000008521 reorganization Effects 0.000 description 1
• 210000002345 respiratory system Anatomy 0.000 description 1
• 230000004043 responsiveness Effects 0.000 description 1
• 230000000284 resting effect Effects 0.000 description 1
• 108091008146 restriction endonucleases Proteins 0.000 description 1
• 230000006159 retinylidene Schiff base formation Effects 0.000 description 1
• 239000002336 ribonucleotide Substances 0.000 description 1
• 125000002652 ribonucleotide group Chemical group 0.000 description 1
• 102220126190 rs556840308 Human genes 0.000 description 1
• 210000000468 rubriblast Anatomy 0.000 description 1
• 210000003296 saliva Anatomy 0.000 description 1
• CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
• 210000005212 secondary lymphoid organ Anatomy 0.000 description 1
• 230000003248 secreting effect Effects 0.000 description 1
• 210000000582 semen Anatomy 0.000 description 1
• 238000000926 separation method Methods 0.000 description 1
• 238000012163 sequencing technique Methods 0.000 description 1
• 210000002966 serum Anatomy 0.000 description 1
• 229960002930 sirolimus Drugs 0.000 description 1
• QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 1
• 150000003384 small molecules Chemical class 0.000 description 1
• 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
• 210000000952 spleen Anatomy 0.000 description 1
• 230000002269 spontaneous effect Effects 0.000 description 1
• 230000006641 stabilisation Effects 0.000 description 1
• 238000011105 stabilization Methods 0.000 description 1
• 238000010186 staining Methods 0.000 description 1
• 210000000130 stem cell Anatomy 0.000 description 1
• 230000000707 stereoselective effect Effects 0.000 description 1
• 210000002536 stromal cell Anatomy 0.000 description 1
• 208000025889 stromal keratitis Diseases 0.000 description 1
• 230000035322 succinylation Effects 0.000 description 1
• 238000010613 succinylation reaction Methods 0.000 description 1
• 230000010741 sumoylation Effects 0.000 description 1
• 239000013589 supplement Substances 0.000 description 1
• 210000004243 sweat Anatomy 0.000 description 1
• 238000003786 synthesis reaction Methods 0.000 description 1
• 230000002194 synthesizing effect Effects 0.000 description 1
• 210000001138 tear Anatomy 0.000 description 1
• ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical group C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
• 229940124597 therapeutic agent Drugs 0.000 description 1
• 150000003573 thiols Chemical class 0.000 description 1
• 230000006694 transcriptional co-activation Effects 0.000 description 1
• 230000002463 transducing effect Effects 0.000 description 1
• 238000001890 transfection Methods 0.000 description 1
• 210000004881 tumor cell Anatomy 0.000 description 1
• 102000003390 tumor necrosis factor Human genes 0.000 description 1
• 241001430294 unidentified retrovirus Species 0.000 description 1
• 210000002700 urine Anatomy 0.000 description 1
• 239000004474 valine Substances 0.000 description 1
• 239000003981 vehicle Substances 0.000 description 1
• 230000029663 wound healing Effects 0.000 description 1